Skip to main content
. 2022 Mar 16;8(1):e002160. doi: 10.1136/rmdopen-2021-002160

Figure 2.

Figure 2

(A) Relapse-free survival and (B) overall survival probabilities for the 62 ANCA-negative granulomatosis with polyangiitis patients versus 665 PR3-ANCA–positive and MPO-ANCA–positive GPA patients. ANCA, antineutrophil cytoplasm antibody; MPO, myeloperoxidase; PR3, proteinase-3.